Surgical Science Sweden AB (publ)
SUSRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,658 | $7,270 | $6,278 | $8,202 |
| - Cash | $597 | $610 | $613 | $968 |
| + Debt | $2 | $2 | $2 | $235 |
| Enterprise Value | $4,062 | $6,661 | $5,667 | $7,469 |
| Revenue | $264 | $209 | $251 | $252 |
| % Growth | 26% | -16.6% | -0.3% | – |
| Gross Profit | $170 | $136 | $173 | $170 |
| % Margin | 64.6% | 65.2% | 68.8% | 67.6% |
| EBITDA | $27 | -$22 | $24 | $39 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |
| Net Income | $20 | -$20 | $33 | $36 |
| % Margin | 7.7% | -9.6% | 13.3% | 14.4% |
| EPS Diluted | 0.4 | -0.39 | 0.65 | 0.71 |
| % Growth | 202.6% | -160% | -8.5% | – |
| Operating Cash Flow | -$4 | $16 | -$5 | $57 |
| Capital Expenditures | -$11 | -$13 | -$11 | -$12 |
| Free Cash Flow | -$15 | $4 | -$16 | $45 |